Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CIGNA Corporation    CI

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Cigna profit misses Wall Street target

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 01:05pm CET

Insurer Cigna Corp (>> CIGNA Corporation) posted a lower-than-expected first-quarter profit on Thursday, as earnings slipped in its segment offering disability and life coverage policies.

Insurer Cigna Corp (>> CIGNA Corporation) posted a lower-than-expected first-quarter profit on Thursday, as earnings slipped in its segment offering disability and life coverage policies.

Cigna is the latest health insurer to miss Wall Street's earnings target in the period, following Aetna Inc (>> Aetna Inc.), Coventry Health Care (>> Coventry Health Care, Inc.) and Humana Inc (>> Humana Inc.).

Cigna did raise its full-year earnings forecast.

Net income fell to $371 million, or $1.28 per share, from $413 million, or $1.51 per share, a year earlier.

Excluding special items, Cigna's earnings of $1.28 per share fell 2 cents below the analysts' average estimate, according to Thomson Reuters I/B/E/S.

Revenue jumped 25 percent to $6.79 billion, helped by the acquisition of Medicare specialist HealthSpring.

Profit in the main healthcare segment rose 6.5 percent to $262 million, helped by rising membership in its plans.

But earnings in its disability and life segment fell 16 percent to $65 million. The company cited strategic investments in its disability management programs as a factor pushing down profit.

Cigna forecast 2012 earnings of $5.20 to $5.55 per share. It previously projected $5.00 to $5.40. Analysts have been looking for $5.41.

(Reporting by Lewis Krauskopf in New York; Editing by Lisa Von Ahn)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CIGNA CORPORATION
01/13 CIGNA : and Scripps Health Form Alliance to Deliver Innovative Health Plans in S..
01/13 CIGNA CORPORATION : Blog Coverage Expensive EpiPen Proves Costly for Mylan as Ci..
01/13 CIGNA : Launches Fingerprint Access Feature to Help Customers Manage Their Healt..
01/12DJCigna Drops Coverage of Mylan's EpiPen for Cheaper Generic -- Update
01/12 CIGNA CORPORATION : Announces Appearance at the 35th Annual J.P. Morgan Healthca..
01/12DJCIGNA : Drops Coverage of Mylan's EpiPen for Cheaper Generic
01/11 CIGNA : and Scripps Health Form Alliance to Deliver Innovative Health Plans in S..
01/11 CIGNA CORPORATION (NASDAQ : CI) Files An 8-K Results of Operations and Financial..
01/11 CIGNA : Scripps Health Form Alliance to Deliver Innovative Health Plans in San D..
01/10 CIGNA : Insurers tell Obama’s benefits team to kick FAQ addiction
More news
Sector news : Managed Healthcare - NEC
01/10DJUNITEDHEALTH : Optum to Acquire Surgical Care in $2.3 Billion Deal -- WSJ
01/09DJMARKET SNAPSHOT : Stock Market Dips Ahead Of Corporate-earnings Kickoff
01/09DJUNITEDHEALTH : Optum to Acquire Surgical Care Affiliates for $2.3 Billion
01/09DJMARKET SNAPSHOT : Stock Market Slips Ahead Of Corporate-earnings Kickoff
01/05 Walgreens profit beats estimates on PBM partnerships
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
05:43a Trump vows health 'insurance for everybody'
01/12 WALL STREET BREAKFAST : Apple Sets Its Sights On Hollywood
01/12 Senate takes first step to repeal Obamacare
01/11 Cigna plays hardball with Mylan over EpiPen, drops coverage in favor of Impax..
01/11 Cigna drops EpiPen from coverage
Advertisement
Financials ($)
Sales 2016 39 599 M
EBIT 2016 3 368 M
Net income 2016 1 942 M
Debt 2016 1 292 M
Yield 2016 0,02%
P/E ratio 2016 19,59
P/E ratio 2017 16,02
EV / Sales 2016 0,98x
EV / Sales 2017 0,94x
Capitalization 37 563 M
More Financials
Chart CIGNA CORPORATION
Duration : Period :
CIGNA Corporation Technical Analysis Chart | CI | US1255091092 | 4-Traders
Full-screen chart
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 153 $
Spread / Average Target 4,8%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Mark Marsters Senior Vice President-Group Operations
Thomas A. McCarthy Chief Financial Officer & Executive Vice President
Alan M. Muney Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA CORPORATION9.69%37 563
UNITEDHEALTH GROUP INC1.10%154 004
AETNA INC-1.37%42 919
ANTHEM INC3.31%39 128
HUMANA INC-0.54%30 256
CENTENE CORP10.87%10 706
More Results